Steven Feldman to Antirheumatic Agents
This is a "connection" page, showing publications Steven Feldman has written about Antirheumatic Agents.
Connection Strength
2.062
-
Kazemi A, Cline A, Cardwell LA, Feldman SR. Psoriasis therapy and aortic inflammation - translating statistical to clinical significance. Dermatol Online J. 2018 Sep 15; 24(9).
Score: 0.636
-
Kaminska E, Patel I, Dabade TS, Chang J, Qureshi AA, O'Neill JL, Balkrishnan R, Feldman SR. Comparing the lifetime risks of TNF-alpha inhibitor use to common benchmarks of risk. J Dermatolog Treat. 2013 Apr; 24(2):101-6.
Score: 0.387
-
Egeberg A, Girolomoni G, Feldman SR, Radtke MA, Carrascosa JM, Ghil J, Keum JW, Lee J, Seo H. Real World SB4 (Etanercept Biosimilar) Use in Patients With Psoriasis: Data from the British Association of Dermatologists Biologic Interventions Register (BADBIR). J Drugs Dermatol. 2020 Mar 01; 19(3):316-318.
Score: 0.176
-
Stiff KM, Glines KR, Porter CL, Cline A, Feldman SR. Current pharmacological treatment guidelines for psoriasis and psoriatic arthritis. Expert Rev Clin Pharmacol. 2018 Dec; 11(12):1209-1218.
Score: 0.161
-
Patel N, Nadkarni A, Cardwell LA, Vera N, Frey C, Patel N, Feldman SR. Psoriasis, Depression, and Inflammatory Overlap: A Review. Am J Clin Dermatol. 2017 Oct; 18(5):613-620.
Score: 0.149
-
Feldman SR, Zhao Y, Navaratnam P, Friedman HS, Lu J, Tran MH. Patterns of medication utilization and costs associated with the use of etanercept, adalimumab, and ustekinumab in the management of moderate-to-severe psoriasis. J Manag Care Spec Pharm. 2015 Mar; 21(3):201-9.
Score: 0.124
-
Semble AL, Davis SA, Feldman SR. Lack of information in current guidelines regarding systemic corticosteroids in inflammatory diseases. Dermatol Online J. 2014 Mar 17; 20(3).
Score: 0.116
-
Taylor SL, Petrie M, O'Rourke KS, Feldman SR. Rheumatologists' recommendations on what to do in the dermatology office to evaluate and manage psoriasis patients' joint symptoms. J Dermatolog Treat. 2009; 20(6):350-3.
Score: 0.081
-
Revicki DA, Menter A, Feldman S, Kimel M, Harnam N, Willian MK. Adalimumab improves health-related quality of life in patients with moderate to severe plaque psoriasis compared with the United States general population norms: results from a randomized, controlled Phase III study. Health Qual Life Outcomes. 2008 Oct 02; 6:75.
Score: 0.080
-
Gottlieb A, Korman NJ, Gordon KB, Feldman SR, Lebwohl M, Koo JY, Van Voorhees AS, Elmets CA, Leonardi CL, Beutner KR, Bhushan R, Menter A. Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 2. Psoriatic arthritis: overview and guidelines of care for treatment with an emphasis on the biologics. J Am Acad Dermatol. 2008 May; 58(5):851-64.
Score: 0.077
-
Baumrin E, Van Voorhees A, Garg A, Feldman SR, Merola JF. A systematic review of herpes zoster incidence and consensus recommendations on vaccination in adult patients on systemic therapy for psoriasis or psoriatic arthritis: From the Medical Board of the National Psoriasis Foundation. J Am Acad Dermatol. 2019 Jul; 81(1):102-110.
Score: 0.041
-
Clowse ME, Feldman SR, Isaacs JD, Kimball AB, Strand V, Warren RB, Xibillé D, Chen Y, Frazier D, Geier J, Proulx J, Marren A. Pregnancy Outcomes in the Tofacitinib Safety Databases for Rheumatoid Arthritis and Psoriasis. Drug Saf. 2016 08; 39(8):755-62.
Score: 0.034